Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Cardiovascular Systems fourth-quarter revenue increases 15% to $18.0 million

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal fourth quarter and year ended June 30, 2010.

11 Aug 2010

General Nutrition Centers second-quarter net income increases 42.5% to $25.6 million

General Nutrition Centers, Inc., a leading global specialty retailer of nutritional products, today reported its financial results for the quarter ended June 30, 2010.

10 Aug 2010

Theragenics reports consolidated revenue of $20.8M for second-quarter 2010

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2010.

10 Aug 2010

Vanguard Management, Go Healthy announce consulting, management and distribution agreement

Vanguard Management Corp (a business unit of Vanguard Minerals Corp) announced that the company has signed a comprehensive consulting, management and distribution agreement with Go Healthy, Inc, a marketer of innovative nutrition products, namely Cholesterade.

10 Aug 2010

Columbus hospital receives PPMD grant to conduct clinical testing for Duchenne

Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), will award a $600,000 grant to Nationwide Children's Hospital in Columbus, Ohio to conduct clinical testing of a promising gene therapy technique for muscle disease.

10 Aug 2010

China Sky One second-quarter 2010 total revenues up 26.7%

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced record financial results for the second quarter of 2010.

10 Aug 2010

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the Massachusetts Institute of Technology (MIT), The University of British Columbia (UBC), AlCana Technologies, Inc., and Tekmira Pharmaceuticals Corporation, presented results from multiple ongoing research efforts regarding the discovery of novel technologies for the systemic delivery of RNAi therapeutics.

10 Aug 2010

Anika second-quarter product revenue increases 56% to $13.7 million

Anika Therapeutics, Inc., a leader in products for tissue protection, healing, and repair, based on hyaluronic acid technology, today reported financial results for the quarter ended June 30, 2010.

10 Aug 2010

Progenics second-quarter total revenue decreases to $2.3 million

Progenics Pharmaceuticals, Inc. today announced its results of operations for the second quarter and six months ended June 30, 2010.

9 Aug 2010

Sparton Medical Systems acquires Delphi Medical's contract manufacturing business assets

Sparton Corporation, a supplier of complex and reliable electronic and electro-mechanical products, sub-assemblies and related services to the highly regulated Medical, Defense & Security, and Aerospace markets announces that on August 6, 2010 its wholly owned subsidiary, Sparton Medical Systems Colorado, LLC, completed its previously announced acquisition of certain assets related to the contract manufacturing business of Delphi Medical Systems, LLC. The all-cash transaction is valued at approximately $8.0 million.

9 Aug 2010

IDFA applauds U.S Senate Committee for child nutrition legislation

The International Dairy Foods Association applauded the leadership of Chairman Blanche Lincoln (D-AR), U.S. Senate Committee on Agriculture, Nutrition and Forestry, on the passage of child nutrition legislation that strengthens federal feeding programs. The federal child nutrition programs include the National School Lunch Program, School Breakfast Program, Special Supplemental Program for Women Infants, and Children (WIC) and the Child and Adult Care Food Program.

7 Aug 2010

ADVENTRX second-quarter net loss applicable to common stock increases to $5.0 million

ADVENTRX Pharmaceuticals, Inc. today reported financial results for the three and six months ended June 30, 2010.

7 Aug 2010

Opexa Therapeutics aims to complete planned experiments, develop clinical study protocols

Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis (MS), today reported financial results for the quarter ended June 30, 2010 and provided an update on its corporate developments.

7 Aug 2010

Female Health Company third-quarter net revenues decrease 75% to $1.8 million

The Female Health Company, which manufactures and markets the FC2 Female Condom®, today reported its operating results for the third quarter and first nine months of FY2010.

7 Aug 2010

Halozyme second-quarter revenue increases to $3.2 million

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the second quarter ended June 30, 2010.

7 Aug 2010

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

Hemispherx Biopharma, Inc. announced its financial results for the three months ended June 30, 2010. The net loss (including non-cash expenses) for the 2nd fiscal quarter was approximately $3,676,000 or $0.03 per share compared to a loss of approximately $3,870,000 or $0.04 per share for the same period in 2009.

7 Aug 2010

FDA seeks ban on Regenerative Sciences for violating cGMP

The U.S. Food and Drug Administration is seeking an injunction in federal court against Regenerative Sciences LLC, of Broomfield, Colo., citing violations of current good manufacturing practice (cGMP) that cause its cultured cell product to be adulterated. The product is also misbranded due to the lack of adequate directions for use and the failure to bear the "Rx only" symbol.

7 Aug 2010

Alkermes reports $42.3 million revenue for first-quarter fiscal 2011

Alkermes, Inc. today reported financial results for its first quarter of fiscal 2011, which ended on June 30, 2010.

7 Aug 2010

Cornerstone announces ANDA filing for generic Tussionex

Cornerstone Therapeutics Inc., a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that its product candidate CRTX-067 is an ANDA filing for a generic 10 mg chlorpheniramine polistirex/8 mg hydrocodone polistirex suspension product that will be a generic substitute for the product currently sold under the Tussionex brand name by UCB, Inc.

7 Aug 2010

Novavax reports net loss of $9.4M for second-quarter 2010

Novavax, Inc. today announced financial results for the second quarter ended June 30, 2010.

7 Aug 2010

Manufacturing News and Research

Further Reading

Cardiovascular Systems fourth-quarter revenue increases 15% to $18.0 million

General Nutrition Centers second-quarter net income increases 42.5% to $25.6 million

Theragenics reports consolidated revenue of $20.8M for second-quarter 2010

Vanguard Management, Go Healthy announce consulting, management and distribution agreement

Columbus hospital receives PPMD grant to conduct clinical testing for Duchenne

China Sky One second-quarter 2010 total revenues up 26.7%

Alnylam Pharmaceuticals reports significant progress in discovery of novel technologies for systemic delivery of RNAi therapeutics

Anika second-quarter product revenue increases 56% to $13.7 million

Progenics second-quarter total revenue decreases to $2.3 million

Sparton Medical Systems acquires Delphi Medical's contract manufacturing business assets

IDFA applauds U.S Senate Committee for child nutrition legislation

ADVENTRX second-quarter net loss applicable to common stock increases to $5.0 million

Opexa Therapeutics aims to complete planned experiments, develop clinical study protocols

Female Health Company third-quarter net revenues decrease 75% to $1.8 million

Halozyme second-quarter revenue increases to $3.2 million

Hemispherx Biopharma second-quarter net loss decreases to $3.67 million

FDA seeks ban on Regenerative Sciences for violating cGMP

Alkermes reports $42.3 million revenue for first-quarter fiscal 2011

Cornerstone announces ANDA filing for generic Tussionex

Novavax reports net loss of $9.4M for second-quarter 2010

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News